Newspaper says Merck tried to protect Vioxx sales
617970
Merck &amp; Co.&#39;s shares (MRK) fell 9.7 percent to the lowest price in almost nine years after the Wall Street Journal said yesterday the drugmaker tried for years to stop safety concerns from hurting sales of its Vioxx painkiller.
424010
Merck said that it would stop selling Vioxx because a study found that it doubled patients' risk of heart attack and strokes.
315924
Merck &amp; Co.&#39;s Vioxx painkiller showed heart risk in studies four years before the drug was recalled, and it should have been pulled from the market then, according to a study published in the medical journal Lancet.
156669
Drugs giant Merck & Co. which pulled  its blockbuster painkiller Vioxx from shelves in September, is  about to become the target of hundreds of plaintiffs' lawyers,  the New York Times reported on Friday.
506626
Merck pulled Vioxx from the market on September 30th, saying it was acting in the best interest of patients. But internal documents reportedly show the company knew as far back as 2000 that
213386
NEW YORK - At Merck&#39;s annual analyst meeting, Chief Executive Raymond Gilmartin defended his company&#39;s handling of Vioxx and outlined changes that he says could help restore Merck&#39;s health.
253668
Shares of Merck (MRK) plunged more than 7% Monday after a report said the pharmaceutical giant apparently hid or denied evidence for years that its blockbuster arthritis drug Vioxx causes heart problems.
373538
Merck&#39;s board of directors has formed a special committee and hired independent counsel to conduct a review of the US drugmaker&#39;s actions with Vioxx, a popular painkiller it withdrew because of increased heart risks.
427704
WHITEHOUSE STATION, NJ - Shares of Merck &amp; Co. plunged nearly 10 percent Monday after a media report said documents show the pharmaceutical giant hid or denied evidence for years that its blockbuster arthritis drug Vioxx causes heart problems.
261328
WASHINGTON -- Merck &amp; Co., which stopped selling its blockbuster Vioxx drug due to heart problems caused by the painkiller, manipulated the design of a key study for a new painkiller to minimize its cardiovascular risks and increase chances of approval, a federal whistle-blower says.
375780
Merck &amp; Co. said it&#39;s withdrawing its Vioxx painkiller, which generated $2.5 billion in worldwide sales last year, because of data showing an increased risk of heart attack and stroke.
565054
NEW YORK - The state and city sued Merck &amp; Co. Inc. yesterday, saying the drug maker defrauded Medicaid and other government insurance programs by hiding the risks of heart problems associated with its pain medication Vioxx.
313849
Merck &amp; Co., under siege because of lost revenues from its recalled blockbuster arthritis drug Vioxx, will cut about 5,100 jobs by year&#39;s end, more than originally planned, and will slash hundreds of millions of dollars in spending, Chairman Raymond V
592608
Lawyers for customers suing Merck &amp; Co. want to question CEO Raymond Gilmartin about what he knew about the dangers of Vioxx before the company withdrew the drug from the market because of health hazards.
20275
Shares of Merck &amp; Co. plunged more than 7 percent Monday after a media report said that documents show the pharmaceutical giant hid or denied evidence for years that its blockbuster arthritis drug Vioxx cause heart problems.
547958
Merck officials had evidence as far back as 2001 that Vioxx might not help thousands of users of the arthritis and pain drug.
617440
NEW YORK (Dow Jones/AP) _ The New York state comptroller sued Merck &amp; Co., claiming the drug maker hid certain risks associated with the painkiller Vioxx.